Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited)

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Preferred Stock [Member]
Series D Preferred Stock [Member]
Preferred Stock [Member]
Series E Preferred Stock [Member]
Common Stock [Member]
Additional paid-in capital [Member]
Accumulated deficit [Member]
Total
Balance at Sep. 30, 2019 $ 5 $ 45 $ 7 $ 30 $ 2,120 $ 15,041,522 $ (16,221,110) $ (1,177,381)
Balance, shares at Sep. 30, 2019 512,996 4,433,375 670,904 3,000,000 211,994,635      
Net income 1,172 1,172
Acquisition of ReadyMed platform in exchange for common shares $ 120 (120)
Acquisition of ReadyMed platform in exchange for common shares, shares 12,000,000      
Balance at Dec. 31, 2019 $ 5 $ 45 $ 7 $ 30 $ 2,240 15,041,402 (16,219,938) (1,176,209)
Balance, shares at Dec. 31, 2019 512,996 4,433,375 670,904 3,000,000 223,994,635      
Balance at Sep. 30, 2020 $ 5 $ 45 $ 7 $ 30 $ 2,240 15,266,718 (16,055,841) (786,796)
Balance, shares at Sep. 30, 2020 512,996 4,433,375 670,904 3,000,000 223,994,635      
Net income 35,424 35,424
Balance at Dec. 31, 2020 $ 5 $ 45 $ 7 $ 30 $ 2,240 $ 15,266,718 $ (16,020,417) $ (751,372)
Balance, shares at Dec. 31, 2020 512,996 4,433,375 670,904 3,000,000 223,994,635